Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;91:1545-1551

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woolfson, R. G.
Right arrow Articles by Yellon, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woolfson, R. G.
Right arrow Articles by Yellon, D. M.

(Circulation. 1995;91:1545-1551.)
© 1995 American Heart Association, Inc.


Articles

Inhibition of Nitric Oxide Synthesis Reduces Infarct Size by an Adenosine-Dependent Mechanism

Robin G. Woolfson, MD; Vanlata C. Patel, BSc; Guy H. Neild, FRCP; Derek M. Yellon, PhD, DSc, FACC, FRSC

From the Department of Nephrology (R.G.W., G.H.N.), Institute of Urology and Nephrology; and The Hatter Institute for Cardiovascular Studies (V.C.P., D.M.Y.), Department of Academic Cardiology, University College London Medical School, London, UK.

Correspondence to Professor D.M. Yellon, The Hatter Institute for Cardiovascular Studies, Department of Academic Cardiology, University College London Medical School, Gower St, London, UK WC1E 6AU.

Background Nitric oxide (NO) is both a potent endogenous vasodilator with potential to attenuate ischemia-reperfusion injury and a mediator of tissue injury. The aim of the present study was to investigate the mechanism by which prior inhibition of NO synthesis can lessen ischemia-reperfusion injury in the isolated rabbit heart.

Methods and Results We examined the effects of inhibition of NO synthesis on infarct size using a model of coronary artery ligation in isolated rabbit hearts perfused at a constant flow rate of 35 mL/min. Infarct size averaged 65% of the zone at risk after 45 minutes of ischemia and 180 minutes of reperfusion. The addition of 30 µmol/L NG-nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthesis, to the perfusate reduced the infarct-to-risk (I/R) ratio to an average of 41% (P<.05 versus control). This effect was abolished by pretreatment with 75.5 µmol/L 8-p-sulfophenyl theophylline (SPT), an adenosine receptor antagonist (I/R ratio, 63%). Ischemic preconditioning (5 minutes of ischemia and 10 minutes of reperfusion) before 45 minutes of ischemia and 3 hours of reperfusion reduced the I/R ratio to an average of 21%, and this was not augmented by pretreatment with L-NAME (I/R ratio, 20%). However, all protection due to preconditioning and L-NAME was lost in hearts pretreated with SPT (I/R ratio, 59%). In a separate set of experiments, adenosine concentration in the coronary perfusate and myocardial lactate concentrations were measured. Treatment with L-NAME increased the average adenosine concentration in the perfusate from 5.7 µmol/L per 100 g of heart (control) to a peak of 24.0 µmol/L per 100 g of heart; however, there was no effect on average myocardial lactate concentration (control, 4.6 µmol/g dry wt; L-NAME, 5.5 µmol/g dry wt). In contrast, after 5 minutes of global ischemia, the average adenosine concentration peaked at 139.0 µmol/L per 100 g of heart, and the average myocardial lactate concentration increased to 27.1 µmol/g dry wt.

Conclusions Infarct size limitation after inhibition of NO synthesis shares a common mechanism with that of ischemic preconditioning and is dependent on the release of adenosine. However, in this model, adenosine release after inhibition of NO synthesis is not secondary to myocardial ischemia. The protection of the heart against ischemic injury by adenosine appears to be concentration dependent.


Key Words: nitric oxide • adenosine • reperfusion • ischemia




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. V. Cohen, X.-M. Yang, and J. M. Downey
Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies
Cardiovasc Res, May 1, 2006; 70(2): 231 - 239.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Gamboa, R. Abraham, A. Diedrich, C. Shibao, S. Y. Paranjape, G. Farley, and I. Biaggioni
Role of Adenosine and Nitric Oxide on the Mechanisms of Action of Dipyridamole
Stroke, October 1, 2005; 36(10): 2170 - 2175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Wang, C. Yin, L. Xi, and R. C. Kukreja
Opening of Ca2+-activated K+ channels triggers early and delayed preconditioning against I/R injury independent of NOS in mice
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2070 - H2077.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Q. Qin, X.-M. Yang, L. Cui, S. D. Critz, M. V. Cohen, N. C. Browner, T. M. Lincoln, and J. M. Downey
Exogenous NO triggers preconditioning via a cGMP- and mitoKATP-dependent mechanism
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H712 - H718.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Schulz, M. Kelm, and G. Heusch
Nitric oxide in myocardial ischemia/reperfusion injury
Cardiovasc Res, February 15, 2004; 61(3): 402 - 413.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Galinanes and A. G Fowler
Role of clinical pathologies in myocardial injury following ischaemia and reperfusion
Cardiovasc Res, February 15, 2004; 61(3): 512 - 521.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. M. YELLON and J. M. DOWNEY
Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology
Physiol Rev, October 1, 2003; 83(4): 1113 - 1151.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Peart and J. P Headrick
Adenosine-mediated early preconditioning in mouse: protective signaling and concentration dependent effects
Cardiovasc Res, June 1, 2003; 58(3): 589 - 601.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Lebuffe, P. T. Schumacker, Z.-H. Shao, T. Anderson, H. Iwase, and T. L. Vanden Hoek
ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H299 - H308.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. ZINGARELLI, P. W. HAKE, Z. YANG, M. O'CONNOR, A. DENENBERG, and H. R. WONG
Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-{kappa}B and AP-1 activation and enhances myocardial damage
FASEB J, March 1, 2002; 16(3): 327 - 342.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. R Cross, E. Murphy, W. J Koch, and C. Steenbergen
Male and female mice overexpressing the {beta}2-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide
Cardiovasc Res, February 15, 2002; 53(3): 662 - 671.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. M Bell and D. M Yellon
The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice
Cardiovasc Res, November 1, 2001; 52(2): 274 - 280.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R D Rakhit and M S Marber
Nitric oxide: an emerging role in cardioprotection?
Heart, October 1, 2001; 86(4): 368 - 372.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Costa, N. J. Christensen, G. Farley, and I. Biaggioni
NO modulates norepinephrine release in human skeletal muscle: implications for neural preconditioning
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1494 - R1498.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Rossoni, B. Manfredi, V. D. G. Colonna, M. Bernareggi, and F. Berti
The Nitroderivative of Aspirin, NCX 4016, Reduces Infarct Size Caused by Myocardial Ischemia-Reperfusion in the Anesthetized Rat
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 380 - 387.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Lochner, E. Marais, S. Genade, and J. A. Moolman
Nitric oxide: a trigger for classic preconditioning?
Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2752 - H2765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. J. Tanhehco, K. Yasojima, P. L. McGeer, E. G. McGeer, and B. R. Lucchesi
Preconditioning reduces myocardial complement gene expression in vivo
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H1157 - H1165.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Tong, W. Chen, C. Steenbergen, and E. Murphy
Ischemic Preconditioning Activates Phosphatidylinositol-3-Kinase Upstream of Protein Kinase C
Circ. Res., August 18, 2000; 87(4): 309 - 315.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. K. Kudej, S.-J. Kim, Y.-T. Shen, J. B. Jackson, A. B. Kudej, G.-P. Yang, S. P. Bishop, and S. F. Vatner
Nitric oxide, an important regulator of perfusion-contraction matching in conscious pigs
Am J Physiol Heart Circ Physiol, July 1, 2000; 279(1): H451 - H456.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kanno, P. C. Lee, Y. Zhang, C. Ho, B. P. Griffith, L. L. Shears II, and T. R. Billiar
Attenuation of Myocardial Ischemia/Reperfusion Injury by Superinduction of Inducible Nitric Oxide Synthase
Circulation, June 13, 2000; 101(23): 2742 - 2748.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. Sasaki, T. Sato, A. Ohler, B. O’Rourke, and E. Marban
Activation of Mitochondrial ATP-Dependent Potassium Channels by Nitric Oxide
Circulation, February 1, 2000; 101(4): 439 - 445.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. L. Ma, F. Gao, G.-L. Liu, B. L. Lopez, T. A. Christopher, J. M. Fukuto, D. A. Wink, and M. Feelisch
Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury
PNAS, December 7, 1999; 96(25): 14617 - 14622.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Shinmura, X.-L. Tang, H. Takano, M. Hill, and R. Bolli
Nitric oxide donors attenuate myocardial stunning in conscious rabbits
Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2495 - H2503.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Csonka, Z. Szilvassy, F. Fulop, T. Pali, I. E. Blasig, A. Tosaki, R. Schulz, and P. Ferdinandy
Classic Preconditioning Decreases the Harmful Accumulation of Nitric Oxide During Ischemia and Reperfusion in Rat Hearts
Circulation, November 30, 1999; 100(22): 2260 - 2266.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. E. Jordan, Z.-Q. Zhao, and J. Vinten-Johansen
The role of neutrophils in myocardial ischemia-reperfusion injury
Cardiovasc Res, September 1, 1999; 43(4): 860 - 878.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart
Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury
Cardiovasc Res, August 15, 1999; 43(3): 698 - 711.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J Bing, T. Yamamoto, M. Yamamoto, R. Kakar, and A. Cohen
New look at myocardial infarction: toward a better aspirin
Cardiovasc Res, July 1, 1999; 43(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. P. Jones, W. G. Girod, A. J. Palazzo, D. N. Granger, M. B. Grisham, D. Jourd'Heuil, P. L. Huang, and D. J. Lefer
Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase
Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1567 - H1573.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Agullo, D. Garcia-Dorado, J. Inserte, A. Paniagua, P. Pyrhonen, J. Llevadot, and J. Soler-Soler
L-Arginine limits myocardial cell death secondary to hypoxia-reoxygenation by a cGMP-dependent mechanism
Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1574 - H1580.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Mori, N. Haramaki, H. Ikeda, and T. Imaizumi
Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs
Cardiovasc Res, October 1, 1998; 40(1): 113 - 113.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Takano, S. Manchikalapudi, X.-L. Tang, Y. Qiu, A. Rizvi, A. K. Jadoon, Q. Zhang, and R. Bolli
Nitric Oxide Synthase Is the Mediator of Late Preconditioning Against Myocardial Infarction in Conscious Rabbits
Circulation, August 4, 1998; 98(5): 441 - 449.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Weinbrenner, G. S Liu, J. M Downey, and M. V Cohen
Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia
Cardiovasc Res, June 1, 1998; 38(3): 676 - 684.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Delaney, P. N. Shepel, and J. D. Geiger
Levels of Endogenous Adenosine in Rat Striatum. I. Regulation by Ionotropic Glutamate Receptors, Nitric Oxide and Free Radicals
J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 561 - 567.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
Y. Ishibashi, D. J. Duncker, J. Zhang, and R. J. Bache
ATP-Sensitive K+ Channels, Adenosine, and Nitric Oxide–Mediated Mechanisms Account for Coronary Vasodilation During Exercise
Circ. Res., February 23, 1998; 82(3): 346 - 359.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Yaoita, K. Ogawa, K. Maehara, and Y. Maruyama
Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor
Circulation, January 27, 1998; 97(3): 276 - 281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Qiu, A. Rizvi, X.-L. Tang, S. Manchikalapudi, H. Takano, A. K. Jadoon, W.-J. Wu, and R. Bolli
Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits
Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2931 - H2936.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. O. Nossuli, R. Hayward, R. Scalia, and A. M. Lefer
Peroxynitrite Reduces Myocardial Infarct Size and Preserves Coronary Endothelium After Ischemia and Reperfusion in Cats
Circulation, October 7, 1997; 96(7): 2317 - 2324.
[Abstract] [Full Text]


Home page
CirculationHome page
T. Minamino, M. Kitakaze, K. Node, H. Funaya, and M. Hori
Inhibition of Nitric Oxide Synthesis Increases Adenosine Production via an Extracellular Pathway Through Activation of Protein Kinase C
Circulation, September 2, 1997; 96(5): 1586 - 1592.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
R. Bolli, Z. A. Bhatti, X.-L. Tang, Y. Qiu, Q. Zhang, Y. Guo, and A. K. Jadoon
Evidence That Late Preconditioning Against Myocardial Stunning in Conscious Rabbits Is Triggered by the Generation of Nitric Oxide
Circ. Res., July 19, 1997; 81(1): 42 - 52.
[Abstract] [Full Text]